HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone.

AbstractPURPOSE:
(4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone (PHT) is a phenstatin analog compound. PHT is a known tubulin inhibitor that has potent cytotoxic activity. In the present study, PHT was synthesized and its antitumor activity was determined using in vitro and in vivo experimental models.
METHODS:
The in vitro cytotoxic activity of the PHT was determined by the MTT assay. The antimitotic and hemolytic effects were determined based on the inhibition of sea urchin embryo development and lysis of mouse erythrocytes, respectively. In vivo antitumor activity was assessed in mice inoculated with sarcoma 180 cells.
RESULTS:
In vitro, PHT displayed cytotoxicity in tumor cell lines, showing IC(50) values in the nanomolar range. In addition, it inhibited sea urchin embryo development during all phases examined, first and third cleavage and blastula stage. However, PHT did not induce hemolysis using mouse erythrocytes, suggesting that the cytotoxicity of PHT does not involve membrane damage. The in vivo study demonstrated tumor inhibition rates of 30.9 and 48.2% for PHT at doses of 20 and 40 mg/kg, respectively. In addition, PHT was also able to increase the response elicited by 5-fluorouracil (5-FU) from 33.3 to 55.7%. The histopathological analysis of liver, kidney, and spleen showed that they were just moderately affected by PHT treatment. Neither enzymatic activity of transaminases nor urea levels were significantly affected. Hematological analysis showed leukopenia after 5-FU treatment, but this effect was prevented when 5-FU was combined with PHT.
CONCLUSIONS:
In conclusion, PHT exhibited in vitro and in vivo antitumor effects without substantial toxicity.
AuthorsHemerson Iury F Magalhães, Daniel P Bezerra, Bruno C Cavalcanti, Diego V Wilke, Rodrigo Rotta, Dênis P de Lima, Adilson Beatriz, Ana Paula N N Alves, Flávio da S Bitencourt, Ingrid S T de Figueiredo, Nylane M N Alencar, Letícia V Costa-Lotufo, Manoel Odorico Moraes, Claudia Pessoa
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 68 Issue 1 Pg. 45-52 (Jul 2011) ISSN: 1432-0843 [Electronic] Germany
PMID20821328 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone
  • Antimetabolites, Antineoplastic
  • Antimitotic Agents
  • Antineoplastic Agents
  • Benzophenones
  • Tubulin Modulators
  • Fluorouracil
Topics
  • Animals
  • Antimetabolites, Antineoplastic (pharmacology, toxicity)
  • Antimitotic Agents
  • Antineoplastic Agents (pharmacology)
  • Benzophenones (pharmacology, toxicity)
  • Cell Enlargement (drug effects)
  • Cell Line, Tumor
  • Embryo, Nonmammalian (drug effects)
  • Erythrocytes (drug effects)
  • Fluorouracil (pharmacology, toxicity)
  • HL-60 Cells
  • Hemolysis
  • Humans
  • Male
  • Mice
  • Sea Urchins (embryology)
  • Tubulin Modulators (pharmacology, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: